Efficacy of Sorafenib in Patients with Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization

Journal Title: Biomedical Journal of Scientific & Technical Research (BJSTR) - Year 2019, Vol 14, Issue 5

Abstract

Background: Transcatheter arterial chemoembolization (TACE) refractoriness is an indication for sorafenib treatment in patients with intermediate-stage hepatocellular carcinoma (HCC). This study aims at evaluating the efficacy of conversion of treatment to sorafenib on overall survival (OS) among trans arterial chemoembolization (TACE)-refractory HCC patients. Methods: This retrospective cohort study included 497 patients with HCC treated with TACE between January 2008 and December 2013 at the Kindai University Hospital. Among those patients, 56 were considered refractory to TACE. These TACE-refractory patients were grouped into two cohorts: a) patients who switched treatment from TACE to sorafenib (sorafenib group) and b) those who continued TACE (TACE group). We evaluated the OS of patients from the initial TACE.Results: Thirty-two patients were classified into the sorafenib group, while 24 patients were in the TACE group. The median OS from the initial TACE was 4.29 years in the sorafenib group and 2.14 years in the TACE group (p < 0.0010).Conclusion: Conversion of treatment to sorafenib might improve the OS in TACE-refractory patients with intermediate-stage HCC. Hence, conversion of treatment should be considered for HCC patients refractory to TACE.

Authors and Affiliations

Tadaaki Arizumic, Tomohiro Minami, Masatoshi Kudo

Keywords

Related Articles

Hexadactyly: A Rare Case

A 2-year-old Caucasian female patient, referred to our Department, presented on physical examination a symmetrical duplication of the 5th finger in both hands and feet. (Figure 1) Bone structures could be also palpated a...

Assessment of Microbial Contamination if “As Received”and “Bench-Top Exposed” Orthodontic Materials: A VitroMicrobiologic Investigation

Introduction: The assumption of sterility of packed materials used in orthodontics may lead practitioners to use them without the necessary sterilization. Hence, this study was undertaken to assess the microbial contamin...

Novel Strategies to Increase Sodium Removal and to Reduce Glucose Exposures in Peritoneal Dialysis

The success of Peritoneal Dialysis (PD) as renal replacement treatment is mainly due to the achievement of dialysis adequacy with a good adaptability to the patients’ needs. Adequate sodium and fluid balance are basic re...

Sedation with Ketamine to Catch Up with a Failed Sedation using Midazolam

Background: The problem of treatment-refractory symptoms is common in palli-ative care practice. In such circumstances, it is possible to sedate with midazolam. We propose here the case of a patien...

An Example of Application of CBM to Intersection- Union Hypotheses Testing

Application of CBM to the testing of the intersection of a sub-set of basic hypotheses against an alternative one is considered. Optimal decision rule allows us to restrict the Type-I and Type-II errors rates on the desi...

Download PDF file
  • EP ID EP585992
  • DOI 10.26717/BJSTR.2019.14.002610
  • Views 142
  • Downloads 0

How To Cite

Tadaaki Arizumic, Tomohiro Minami, Masatoshi Kudo (2019). Efficacy of Sorafenib in Patients with Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization. Biomedical Journal of Scientific & Technical Research (BJSTR), 14(5), 10906-10910. https://europub.co.uk/articles/-A-585992